Home News Drug Discovery & Development

Drug Discovery & Development

Nifty Pharma index in the red; Cipla, Lupin top drags 

New Delhi, November 27, 2017: Pharma stocks CiplaBSE -0.46 % (down 1.70 per cent), GlaxoSmithKline PharmaceuticalsBSE -0.79 % (down 0.92 per cent) and LupinBSE 0.30 % (down 0.42 per cent) were trading down in afternoon trade on Monday, dragging the...

Cipla bets big on cell therapy

Mumbai , March 22,2014 - Stem cells are set to be a major branch of medical treatment, says Cipla Chairman YK Hamied. Regenerative medicine, or cell therapy, is a rapidly emerging area of biomedical research and would be...

AstraZeneca to shut R&D centre in Bangalore

168 research jobs at stake; had during 2012 shed some R&D jobsBangalore January 31, 2014: AstraZeneca, the global pharmaceutical major,  said that it will close its research and development site in Bangalore later this year.  The ‘Avishkar R&D Site’,...

‘New drug for Alzheimer’s, Parkinson’s in the pipeline’

New Delhi December 28, 2013: The Government’s drug price control order may have impacted drug-makers’ profitability, but Chennai-based Arvind Remedies Ltd is unfazed. A new drug to combat Alzheimer’s and Parkinson’s diseases is in the pipeline, says B. Arvind...

Baxter Advances Clinical Practice of Intravenous (IV) Therapy with Launch of Plasma-Lyte A...

  Bangalore, December, 06’2013 - Baxter India Pvt. Ltd. (MD Anish Bafna, www.baxter.in) a subsidiary of global healthcare company, Baxter International Inc. (NYSE:BAX), announced the launch of Plasma-Lyte A (pH 7.4), a physiologically balanced crystalloid solution, having similar electrolyte...

Sun Pharma and Intrexon Form Joint Venture to Develop New Class of Therapeutics for...

Pipeline of Potential Ocular Therapies to Help Millions Worldwide Suffering from Blinding Diseases Mumbai, India, and Germantown, MD, USA, Oct. 26, 2013 – Sun Pharmaceutical Industries Ltd.(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE: 524715), an international specialty pharmaceutical...

The Illustrated Guide to Living with Diabetes in India, a Self-management Guide for Diabetics...

Mumbai, Maharashtra, India, Monday, April 22, 2013 -- (Business Wire India) -- 'The Illustrated Guide to Living with Diabetes in India', a practical guide to self-manage diabetes was launched at Kochi on Friday, April 19, 2013 by Sir Michael Hirst, President, International Diabetes Federation (IDF) during the 5 th World Congress of DiabetesIndia. Dr. Shaukat Sadikot, President - Elect, IDF and Prof. Dr. Jean Claude Mbanya, Past-President, IDF was also present during this occasion. The book authored by The Living with Diabetes in India (LWDI), an online community for people with diabetes with over half a million members - and co-published in India by Popular Prakashan, is now available at leading book stores across India and through online retailers.

Drug Discovery Unit (DDU), University of Dundee Licenses GVK BIO Online SAR Database (GOSTAR)

Hyderabad, Andhra Pradesh, India, Wednesday, April 10, 2013 -- (Business Wire India) -- GVK Biosciences (GVK BIO) today announced that it has licensed its Online SAR Database - GOSTAR to the Drug Discovery Unit (DDU) at the University of Dundee. GOSTAR, a manually curated database, has been developed over the span of a decade by a team comprising of more than 200 curators. The product issued globally in various areas such as pharmaceuticals, academics, government sectors, apart from numerous publications that cite the data contained in GOSTAR. GOSTAR contains over 6 million compounds manually curated through the screening of over 2 million patents and 400,000 journals and it also contains more than 18 million quantitative SAR points.

Developments in Bio-informatics will help drive discoveries

    • Training,  revamp  of  University  system,  Promote  Translation  of  Academicre search, Promoting Bio-Entrepreneurship will accelerate the industry growth

 

  • Synthetic  Biotechnology  has  tremendous  potential,  affordable  gene  sequencing can play a major role in the Food, Energy, fragrance & Flavors

Bharat Biotech and University of Maryland Accelerate Development of New Life Saving Conjugate Vaccine...

Receive USD 4 Million Award from The Wellcome Trust for Development and Clinical Trials Hyderabad, India, June 18, 2012: Bharat Biotech and The University of Maryland Center for  Vaccine Development (“CVD”) announced today a significant milestone achievement– receiving a USD  4 Million Strategic Translation Award from The Wellcome Trust for clinical development of a new  conjugate vaccine including initial clinical trials beginning in three years to prevent the potentially  lethal infectious disease caused by invasive non-typhoidal Salmonella (NTS).   NTS have emerged as an important cause of invasive bloodstream infection in sub-Saharan Africa,  among young children with malaria and malnutrition, and among adults with HIV. Strains of nontyphoidal Salmonella (“NTS”) that can cause systemic disease such as meningitis or sepsis are  particularly common in sub-Saharan Africa; approximately 20 to 30% of children with such invasive  NTS infections die.